Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-05-06 Purchase |
2024-05-07 5:06 pm |
Corvus Pharmaceuticals Inc. | CRVS | Jones William Benton See Remarks |
20,000 | $1.7312 | $34,624 | 173,130 (Direct) |
View |
| 2024-05-06 Purchase |
2024-05-07 5:05 pm |
Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD President and CEO |
577,634 | $1.7312 | $1,000,000 | 2,626,826 (Indirect Direct) |
View |
| 2023-05-15 Purchase |
2023-05-16 4:54 pm |
Corvus Pharmaceuticals Inc. | CRVS | Grais Linda Director |
10,000 | $2.45 | $24,500 | 10,000 (Direct) |
View |
| 2022-12-20 Purchase |
2022-12-20 6:22 pm |
Corvus Pharmaceuticals Inc. | CRVS | Jones William Benton See Remarks |
20,000 | $0.79 | $15,800 | 133,773 (Direct) |
View |
| 2022-12-13 Purchase |
2022-12-15 4:33 pm |
Corvus Pharmaceuticals Inc. | CRVS | LEA LEIV Chief Financial Officer |
34,000 | $0.75409 | $25,639 | 282,444 (Indirect) |
View |
| 2022-12-13 Purchase |
2022-12-15 4:32 pm |
Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD President and CEO |
60,000 | $0.74712 | $44,827 | 1,490,119 (Indirect) |
View |
| 2022-09-28 Purchase |
2022-09-28 5:45 pm |
Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD President and CEO |
25,000 | $0.7628 | $19,070 | 1,430,119 (Indirect Direct) |
View |
| 2022-09-20 Purchase |
2022-09-20 6:58 pm |
Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD President and CEO |
20,000 | $0.81266 | $16,253 | 1,405,119 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-08 Option Award |
2025-04-09 5:26 pm |
N/A 2035-04-08 |
Corvus Pharmaceuticals Inc. | CRVS | van den Broek Richard Director |
30,000 | $0 | 30,000 (Direct) |
View |
Ownership |
2025-04-09 5:26 pm |
N/A N/A |
Corvus Pharmaceuticals Inc. | CRVS | van den Broek Richard Director |
0 | $0 | 160,000 (Indirect) |
View |
| 2024-12-20 Option Award |
2024-12-23 4:40 pm |
N/A 2034-12-20 |
Corvus Pharmaceuticals Inc. | CRVS | Arcara Jeffrey Chief Business Officer |
50,000 | $0 | 50,000 (Direct) |
View |
| 2024-12-20 Option Award |
2024-12-23 4:39 pm |
N/A 2034-12-20 |
Corvus Pharmaceuticals Inc. | CRVS | Jones William Benton See Remarks |
300,000 | $0 | 300,000 (Direct) |
View |
| 2024-12-20 Option Award |
2024-12-23 4:39 pm |
N/A 2034-12-20 |
Corvus Pharmaceuticals Inc. | CRVS | LEA LEIV Chief Financial Officer |
300,000 | $0 | 300,000 (Direct) |
View |
| 2024-12-20 Option Award |
2024-12-23 4:38 pm |
N/A 2034-12-20 |
Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD President and CEO |
750,000 | $0 | 750,000 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-17 6:46 pm |
N/A 2034-06-13 |
Corvus Pharmaceuticals Inc. | CRVS | Grais Linda Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-17 4:48 pm |
N/A 2034-06-13 |
Corvus Pharmaceuticals Inc. | CRVS | CLARK IAN T Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-17 4:44 pm |
N/A 2034-06-13 |
Corvus Pharmaceuticals Inc. | CRVS | Morrison Scott W Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-17 4:43 pm |
N/A 2034-06-13 |
Corvus Pharmaceuticals Inc. | CRVS | Gould Terry P Director 10% Owner |
15,000 | $0 | 3,290,616 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-17 4:41 pm |
N/A 2034-06-13 |
Corvus Pharmaceuticals Inc. | CRVS | Thompson Peter A. Director 10% Owner |
15,000 | $0 | 6,958,654 (Direct) |
View |
| 2024-05-10 Gift |
2024-05-14 5:02 pm |
N/A N/A |
Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD President and CEO |
302,016 | $0 | 1,765,737 (Indirect) |
View |
| 2024-02-28 Option Award |
2024-03-01 5:57 pm |
N/A 2034-02-28 |
Corvus Pharmaceuticals Inc. | CRVS | Arcara Jeffrey Chief Business Officer |
400,000 | $0 | 400,000 (Direct) |
View |
| 2023-12-06 Option Award |
2023-12-08 4:09 pm |
N/A 2033-12-06 |
Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD President and CEO |
500,000 | $0 | 500,000 (Direct) |
View |
| 2023-12-06 Option Award |
2023-12-08 4:08 pm |
N/A 2033-12-06 |
Corvus Pharmaceuticals Inc. | CRVS | LEA LEIV Chief Financial Officer |
200,000 | $0 | 200,000 (Direct) |
View |
| 2023-12-06 Option Award |
2023-12-08 4:07 pm |
N/A 2033-12-06 |
Corvus Pharmaceuticals Inc. | CRVS | Jones William Benton See Remarks |
200,000 | $0 | 200,000 (Direct) |
View |
| 2023-12-06 Option Award |
2023-12-08 4:06 pm |
N/A 2033-12-06 |
Corvus Pharmaceuticals Inc. | CRVS | Mitchell Edith P. Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2023-12-06 Option Award |
2023-12-08 4:05 pm |
N/A 2033-12-06 |
Corvus Pharmaceuticals Inc. | CRVS | Grais Linda Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2023-12-06 Option Award |
2023-12-08 4:04 pm |
N/A 2033-12-06 |
Corvus Pharmaceuticals Inc. | CRVS | CLARK IAN T Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2023-12-06 Option Award |
2023-12-08 4:03 pm |
N/A 2033-12-06 |
Corvus Pharmaceuticals Inc. | CRVS | Morrison Scott W Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2023-12-06 Option Award |
2023-12-08 4:03 pm |
N/A 2033-12-06 |
Corvus Pharmaceuticals Inc. | CRVS | Gould Terry P Director 10% Owner |
15,000 | $0 | 3,290,616 (Direct) |
View |
| 2023-12-06 Option Award |
2023-12-08 4:02 pm |
N/A 2033-12-06 |
Corvus Pharmaceuticals Inc. | CRVS | Thompson Peter A. Director 10% Owner |
15,000 | $0 | 6,958,654 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 5:03 pm |
N/A 2033-06-15 |
Corvus Pharmaceuticals Inc. | CRVS | Thompson Peter A. Director 10% Owner |
15,000 | $0 | 6,958,654 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 5:01 pm |
N/A 2033-06-15 |
Corvus Pharmaceuticals Inc. | CRVS | Gould Terry P Director 10% Owner |
15,000 | $0 | 3,290,616 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 5:00 pm |
N/A 2033-06-15 |
Corvus Pharmaceuticals Inc. | CRVS | CLARK IAN T Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 4:59 pm |
N/A 2033-06-15 |
Corvus Pharmaceuticals Inc. | CRVS | Morrison Scott W Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 4:58 pm |
N/A 2033-06-15 |
Corvus Pharmaceuticals Inc. | CRVS | Grais Linda Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 4:57 pm |
N/A 2033-06-15 |
Corvus Pharmaceuticals Inc. | CRVS | Mitchell Edith P. Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2023-03-31 Option Award |
2023-04-03 4:30 pm |
N/A 2033-03-31 |
Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD President and CEO |
800,000 | $0 | 800,000 (Direct) |
View |